Neuren Pharmaceuticals
NEU.AX
#5608
Rank
HK$7.27 B
Marketcap
HK$56.28
Share price
4.35%
Change (1 day)
-47.22%
Change (1 year)

EPS for Neuren Pharmaceuticals (NEU.AX)

EPS in 2023: HK$6.55

According to Neuren Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$6.55. In 2023 the company made an earnings per share (EPS) of HK$6.55 an increase over its 2022 EPS that were of HK$0.007934.

EPS history for Neuren Pharmaceuticals from 2002 to 2023

Annual EPS

Year EPS Change
2023HK$6.5582396.45%
2022HK$0.007934-102.13%
2021-HK$0.37-27.64%
2020-HK$0.51-12.55%
2019-HK$0.59-446.24%
2018HK$0.17-247.23%
2017-HK$0.12-85.3%
2016-HK$0.78-13.42%
2015-HK$0.9134.36%
2014-HK$0.67-47.14%
2013-HK$1.2883.64%
2012-HK$0.69-28.56%
2011-HK$0.97-46.5%
2010-HK$1.82-3690.16%
2009HK$0.05062-100.76%
2008-HK$6.65-38.72%
2007-HK$10.8511.23%
2006-HK$9.7614.27%
2005-HK$8.54-42.59%
2004-HK$14.872.56%
2003-HK$14.5036.5%
2002-HK$10.62